Litcius/Paper detail

Human epidermal growth factor receptor 2 overexpression is frequently discordant between primary and metastatic urothelial carcinoma and is associated with intratumoral human epidermal growth factor receptor 2 heterogeneity

Claud Grigg, Chad Livasy, Jiaxian He, Aaron Hartman, Peter E. Clark, Jason Zhu, Derek Raghavan, Earle F. Burgess

2020Human Pathology20 citationsDOI

Topics & Concepts

MedicineImmunohistochemistryPrimary tumorHuman Epidermal Growth Factor Receptor 2PathologyConcordanceHER2/neuMetastasisEpidermal growth factor receptorOncologyMetastatic Urothelial CarcinomaInternal medicineReceptorCancerBreast cancerUrothelial carcinomaBladder cancerBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesGastric Cancer Management and Outcomes
Human epidermal growth factor receptor 2 overexpression is frequently discordant between primary and metastatic urothelial carcinoma and is associated with intratumoral human epidermal growth factor receptor 2 heterogeneity | Litcius